RJA
AWH

Raymond James & Associates’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Raymond James & Associates’s Portfolio AWH Stock Details AWH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,015
Closed -$170K – 4285
2021
Q2 		$170K Buy
2,015
+67
+3% +$5.76K ﹤0.01% 3728
2021
Q1 		$197K Buy
1,948
+136
+8% +$14.9K ﹤0.01% 3619
2020
Q4 		$182K Sell
1,812
-67
-4% -$4.47K ﹤0.01% 3434
2020
Q3 		$87K Buy
1,879
+97
+5% +$4.98K ﹤0.01% 3396
2020
Q2 		$103K Buy
+1,782
New +$119K ﹤0.01% 3280

Other funds holding AWH

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Raymond James & Associates's AWH Position: Q3 2021 in Review

Raymond James & Associates sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q3 2021, closing a stake of 2,015 shares — an estimated $170K sold.

Raymond James & Associates first reported a position in AWH in Q2 2020 and held it in 5 quarters. The position peaked at $197K in Q1 2021. 92 funds tracked by Wall St. Rank hold AWH as of Q3 2021.

  • Raymond James & Associates reported no remaining Aspira Women's Health Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Raymond James & Associates sold 2,015 Aspira Women's Health Inc. Common Stock shares in Q3 2021, an estimated $170K.
  • Raymond James & Associates first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • Raymond James & Associates's Aspira Women's Health Inc. Common Stock position peaked at $197K in Q1 2021.
  • 92 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q3 2021.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.